Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

30.93
Delayed Data
As of Jan 13
 -0.17 / -0.55%
Today’s Change
20.07
Today|||52-Week Range
34.06
+0.36%
Year-to-Date

Today’s Trading

Previous close31.10
Today’s open31.15
Day’s range30.80 - 31.65
Volume162,150
Average volume (3 months)258,223
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+58.04%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio154.6
Price/Sales11.37
Price/Book8.30

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...-0.31-1.44%
EGRXEagle Pharmaceutical...+2.94+4.43%
ALDRAlder Biopharmaceuti...+0.50+2.40%
DERMDermira Inc+0.90+3.05%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)$0.07
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs